Ida Taglialatela

Breast cancers arising in subjects with germline BRCA1 or BRCA2 mutations: different biological and clinical entities with potentially diverse therapeutic opportunities.

S. Manoukian, G. Pruneri, A. Vingiani, 2023, Critical reviews in oncology/hematology.

Current Status of Predictive Biomarker Development in Metastatic Renal Cell Carcinoma

P. Giannatempo, G. Procopio, M. Stellato, 2023, Current Oncology Reports.

Melanoma and sex hormones: Pathogenesis, progressive disease and response to treatments.

F. de Braud, L. Di Guardo, Ida Taglialatela, 2024, Tumori.